Cell-Signaling Molecule May Play Key Role in Development of Lupus Kidney Disease.
Volunteer for NIAID-funded clinical studies related to lupus on ClinicalTrials.gov.
Lupus, a disabling and life-threatening autoimmune disease, affects more than 1.5 million Americans, 90 percent of whom are women. It is two to three times more common among African Americans, Native Americans, Hispanics, and Asians, than among Caucasians.
NIAID-supported research on autoimmune diseases, including lupus, focuses on
Read more about NIAID’s Role in Lupus Research.
Last Updated November 24, 2014
Last Reviewed November 24, 2014